TrialJournal of Crohn's & colitis2022

Efficacy and Safety of Maintenance Ustekinumab for Ulcerative Colitis Through 3 Years: UNIFI Long-term Extension.

Maria T Abreu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.